Hypercholesterolemia – Pipeline Review, H1 2012

Global Markets Direct
March 19, 2012
123 Pages - SKU: GMD3811124
Atrial Septal Defect Global Clinical Trials Review, H2, 2014
8/12/2014 | published by: GlobalData
Atrial Septal Defect Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Atrial Septal Defect Global Clinical Trials Review, H2, 2014 provides data on the Atrial Septal Defect clinical trial scenario. This report provides elemental  |  read more...
USD 2,500
Retinal Vein Occlusion - Pipeline Review, H2 2014
8/25/2014 | published by: Global Markets Direct
Retinal Vein Occlusion - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Retinal Vein Occlusion - Pipeline Review, H2 2014’, provides an overview of the Retinal Vein Occlusion’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
USD 2,000
OpportunityAnalyzer: Non-Hodgkin’s B-Cell Lymphoma - Opportunity Analysis and Forecast to 2018
8/25/2014 | published by: GlobalData
OpportunityAnalyzer: Non-Hodgkin’s B-Cell Lymphoma - Opportunity Analysis and Forecast to 2018 Summary The competitive landscape in the B-cell NHL markets in the US, France, Italy, Germany, Spain and the UK is poised to undergo a dramatic shift  |  read more...
USD 7,995
Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H2 2014
8/25/2014 | published by: Global Markets Direct
Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H2 2014’, provides an overview of the Peripheral Artery Occlusive Disease (PAOD)’s therapeutic pipeline. This report  |  read more...
USD 2,000
Diabetic Neuropathy - Pipeline Review, H2 2014
8/25/2014 | published by: Global Markets Direct
Diabetic Neuropathy - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Diabetic Neuropathy - Pipeline Review, H2 2014’, provides an overview of the Diabetic Neuropathy’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Diabetic  |  read more...
USD 2,000
Typhoid Fever - Pipeline Review, H2 2014
8/25/2014 | published by: Global Markets Direct
Typhoid Fever - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Typhoid Fever - Pipeline Review, H2 2014’, provides an overview of the Typhoid Fever’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Typhoid  |  read more...
USD 2,000
Perennial Allergic Rhinitis - Pipeline Review, H2 2014
8/25/2014 | published by: Global Markets Direct
Perennial Allergic Rhinitis - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Perennial Allergic Rhinitis - Pipeline Review, H2 2014’, provides an overview of the Perennial Allergic Rhinitis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
USD 2,000
Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H2 2014
8/25/2014 | published by: Global Markets Direct
Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H2 2014’, provides an overview of the Peripheral Neuropathy (Sensory Neuropathy)’s therapeutic pipeline. This report provides comprehensive information  |  read more...
USD 2,000
Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM
8/20/2014 | published by: GBI Research
Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM Summary GBI Research, the leading business intelligence provider, has released its latest research, Glioblastoma Multiforme  |  read more...
USD 4,995
Severe Psoriasis - Pipeline Review, H2 2014
8/25/2014 | published by: Global Markets Direct
Severe Psoriasis - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Severe Psoriasis - Pipeline Review, H2 2014’, provides an overview of the Severe Psoriasis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Severe  |  read more...
USD 2,000
 

SELECT A LICENSE

    Online Download  USD 500  
    Global Site License  USD 1,500  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!